RE:RE:Why Ranbaxy?truthseeker2012 wrote: Ranbaxy had the technology for the slow release of the drug with the patent. Cipher had the formula for the drug. Ranbaxy were bought out by Sun Pharma late last year as Ranbaxy had lots of troubles throughout their entire organization.
Two technologies added together does not one marketing company make! In other words, this strategy simply combined two technologies, but did not either build a marketing organization, or hand off marketing to a larger company.
Now I fear even if they did get a deal with a larger pharmaceutical to market it, they are going to dilute their profits by splitting with Ranbaxy.
Probably the CEO is right to do this deal that is going to diversify them. No easy way to fix what is broken in the Ranbaxy deal.
The reason TEVA grows share is that they have a well oiled sales machine....